Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Am J Ophthalmol. 2018 Oct 31;198:223–261. doi: 10.1016/j.ajo.2018.10.022

TABLE 9.

Area Under the Curve Statistics for Progression to Overall Advanced Age-Related Macular Degeneration, Geographic Atrophy, and Neovascular Disease in the Derivation and Validation Cohorts at 5, 10, and 12 Years after Baseline.

Derivation Cohort Validation Cohort

Progressors Non-Progressors AUC ± SE Progressors Non-Progressors AUC ± SEa
5 years
Overall advanced AMD 590 4758 0.873 ± 0.008 316 2995 0.852 ± 0.011
GA 280 5063 0.859 ± 0.011 162 2992 0.870 ± 0.014
NV 331 5012 0.853 ± 0.011 159 3119 0.825 ± 0.017
10 years
Overall advanced AMD 1056 3559 0.900 ± 0.005 595 1752 0.876 ± 0.008
GA 579 3946 0.866 ± 0.008 315 1752 0.887 ± 0.010
NV 620 3908 0.861 ± 0.008 302 1910 0.828 ± 0.013
12 years
Overall advanced AMD 1149 4206 0.900 ± 0.005 686 1268 0.896 ± 0.007
GA 578 4777 0.870 ± 0.008 357 1268 0. 899 ± 0.009
NV 677 4678 0.860 ± 0.008 364 1408 0.836 ± 0.012

AMD = age-related macular degeneration; AREDS = Age-Related Eye Disease Study; AUC = area under the curve; GA = geographic atrophy; NV = neovascular disease.

a

Calculated by applying the composite risk score derived from the derivation cohort to the independent validation cohort.